Ingredient

Enavogliflozin

Empagliflozin is a blood sugar-lowering ingredient used to treat type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
6
Single ingredient
3
Combination
3
Prescription medication
6

MFDS ingredient code M283330

What does it do?

Empagliflozin belongs to the class of diabetes medications known as SGLT2 inhibitors. It is used to lower blood sugar by blocking glucose reabsorption in the kidneys.

Empagliflozin inhibits the protein (SGLT2) that reabsorbs glucose in the renal tubules. As a result, glucose is excreted in the urine, leading to a reduction in blood sugar levels.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Empagliflozin is similar to other SGLT2 inhibitors, but there may be differences in the selectivity or duration of action of the drug. This ingredient is expected to provide benefits not only in blood sugar control but also in weight loss and blood pressure reduction.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

6 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.